首页 > 最新文献

Bioactive Materials最新文献

英文 中文
Baiting bacteria with amino acidic and peptidic corona coated defect-engineered antimicrobial nanoclusters for optimized wound healing 用氨基酸和肽电晕涂层缺陷工程抗菌纳米团簇诱杀细菌,优化伤口愈合
IF 18 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-09-24 DOI: 10.1016/j.bioactmat.2024.09.010
Maonan Wang , Houjuan Zhu , Yuling Xue , Yanxia Duan , Hua Tian , Qi Liu , Yuzhu Zhang , Zibiao Li , Xian Jun Loh , Enyi Ye , Gang Yin , Xuemei Wang , Xianguang Ding , David Tai Leong
Keeping steps ahead of the bacteria in the race for more efficacious antibacterial strategies is increasingly difficult with the advent of bacterial resistance genes. Herein, we engineered copper sulfide nanoclusters (CuSx NCs) with variable sulfur defects for enhanced dual-treatment of bacterial infections by manipulating photothermal effects and Fenton-like activity. Next, by encasing CuSx NCs with a complex mixture of amino acids and short peptides derived from Luria-Bertani bacterial culture media as a protein corona, we managed to coax E. Coli to take up these CuSx NCs. As a whole, Amino-Pep-CuSx NCs was perceived as a food source and actively consumed by bacteria, enhancing their effective uptake by at least 1.5-fold greater than full length BSA protein BSA-corona CuSx NCs. Through strategically using defect-engineering, we successfully fine-tune photothermal effect and Fenton-like capacity of CuSx NCs. Increased sulfur defects lead to reduced but sufficient heat generation under solar-light irradiation and increased production of toxic hydroxyl radicals. By fine-tuning sulfur defects during synthesis, we achieve CuSx NCs with an optimal synergistic effect, significantly enhancing their bactericidal properties. These ultra-small and biodegradable CuSx NCs can rapidly break down after treatment for clearance. Thus, Amino-Pep-CuSx NCs demonstrate effective eradication of bacteria both in vitro and in vivo because of their relatively high uptake, optimal balanced photothermal and chemodynamic outcomes. Our study offers a straightforward and efficient method to enhance bacterial uptake of next generation of antibacterial agents.
随着细菌耐药基因的出现,要想在更有效的抗菌策略竞争中领先细菌一步变得越来越困难。在这里,我们设计了具有可变硫缺陷的硫化铜纳米簇(CuSx NCs),通过操纵光热效应和芬顿类活性,增强了对细菌感染的双重治疗。接下来,我们用从 Luria-Bertani 细菌培养基中提取的氨基酸和短肽的复杂混合物包裹 CuSx NCs 作为蛋白质冠,成功地诱导大肠杆菌吸收这些 CuSx NCs。大肠杆菌吸收这些 CuSx NCs。从整体上看,Amino-Pep-CuSx NCs 被细菌视为一种食物来源并被其主动摄取,其有效摄取量比全长 BSA 蛋白质 BSA-Corona CuSx NCs 至少高出 1.5 倍。通过战略性地利用缺陷工程,我们成功地微调了 CuSx NCs 的光热效应和芬顿类能力。硫缺陷的增加导致在太阳光照射下产生的热量减少但足够,并增加了有毒羟基自由基的产生。通过在合成过程中对硫缺陷进行微调,我们获得了具有最佳协同效应的 CuSx NCs,显著增强了它们的杀菌性能。这些超小型、可生物降解的 CuSx NCs 可在处理后迅速分解清除。因此,Amino-Pep-CuSx NCs 因其相对较高的吸收率、最佳的光热和化学动力学平衡效果,在体外和体内都能有效地消灭细菌。我们的研究为提高细菌对下一代抗菌剂的吸收提供了一种直接有效的方法。
{"title":"Baiting bacteria with amino acidic and peptidic corona coated defect-engineered antimicrobial nanoclusters for optimized wound healing","authors":"Maonan Wang ,&nbsp;Houjuan Zhu ,&nbsp;Yuling Xue ,&nbsp;Yanxia Duan ,&nbsp;Hua Tian ,&nbsp;Qi Liu ,&nbsp;Yuzhu Zhang ,&nbsp;Zibiao Li ,&nbsp;Xian Jun Loh ,&nbsp;Enyi Ye ,&nbsp;Gang Yin ,&nbsp;Xuemei Wang ,&nbsp;Xianguang Ding ,&nbsp;David Tai Leong","doi":"10.1016/j.bioactmat.2024.09.010","DOIUrl":"10.1016/j.bioactmat.2024.09.010","url":null,"abstract":"<div><div>Keeping steps ahead of the bacteria in the race for more efficacious antibacterial strategies is increasingly difficult with the advent of bacterial resistance genes. Herein, we engineered copper sulfide nanoclusters (CuS<sub>x</sub> NCs) with variable sulfur defects for enhanced dual-treatment of bacterial infections by manipulating photothermal effects and Fenton-like activity. Next, by encasing CuS<sub>x</sub> NCs with a complex mixture of amino acids and short peptides derived from Luria-Bertani bacterial culture media as a protein corona, we managed to coax E. Coli to take up these CuS<sub>x</sub> NCs. As a whole, Amino-Pep-CuS<sub>x</sub> NCs was perceived as a food source and actively consumed by bacteria, enhancing their effective uptake by at least 1.5-fold greater than full length BSA protein BSA-corona CuS<sub>x</sub> NCs. Through strategically using defect-engineering, we successfully fine-tune photothermal effect and Fenton-like capacity of CuS<sub>x</sub> NCs. Increased sulfur defects lead to reduced but sufficient heat generation under solar-light irradiation and increased production of toxic hydroxyl radicals. By fine-tuning sulfur defects during synthesis, we achieve CuS<sub>x</sub> NCs with an optimal synergistic effect, significantly enhancing their bactericidal properties. These ultra-small and biodegradable CuS<sub>x</sub> NCs can rapidly break down after treatment for clearance. Thus, Amino-Pep-CuS<sub>x</sub> NCs demonstrate effective eradication of bacteria both <em>in vitro</em> and <em>in vivo</em> because of their relatively high uptake, optimal balanced photothermal and chemodynamic outcomes. Our study offers a straightforward and efficient method to enhance bacterial uptake of next generation of antibacterial agents.</div></div>","PeriodicalId":8762,"journal":{"name":"Bioactive Materials","volume":"42 ","pages":"Pages 628-643"},"PeriodicalIF":18.0,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2452199X24003979/pdfft?md5=9a90ec7de295592d40cd42dc24135b05&pid=1-s2.0-S2452199X24003979-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142314336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decellularized liver scaffolds for constructing drug-metabolically functional ex vivo human liver models 用于构建药物代谢功能性体内外人体肝脏模型的脱细胞肝脏支架
IF 18 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-09-23 DOI: 10.1016/j.bioactmat.2024.09.029
Juan Liu , Ariel Hanson , Wenzhen Yin , Qiao Wu , Eliane Wauthier , Jinmei Diao , Timothy Dinh , Jeff Macdonald , Ruihong Li , Masahiko Terajima , Mitsuo Yamauchi , Ziye Chen , Praveen Sethupathy , Jiahong Dong , Lola M. Reid , Yunfang Wang
The creation of ex vivo human liver models has long been a critical objective in academic, clinical, and pharmaceutical research, particularly for drug development, where accurate evaluation of hepatic metabolic dynamics is crucial. We have developed a bioengineered, perfused, organ-level human liver model that accurately replicates key liver functions, including metabolic activities, and protein synthesis, thus addressing some of the limitations associated with traditional liver monolayers, organoids, and matrix-embedded liver cells. Our approach utilizes liver-specific biomatrix scaffolds, prepared using an innovative protocol and fortified with matrix components that facilitate cellular interactions. These scaffolds, when seeded with human fetal liver cells or co-seeded with liver parenchymal and endothelial cell lines, enable the formation of three-dimensional (3D) human livers with enhanced cellular organization. The “recellularized tissue-engineered livers” (RCLs) have undergone various analyses, demonstrating the capability for establishing liver microenvironments ex vivo. Within 7–14 days, the RCLs exhibit evidence of liver differentiation and metabolic capabilities, underscoring the potential for use in drug metabolism and toxicity studies. Although our study represents a significant step forward, we acknowledge the need for direct comparisons with existing models and further research to fully elucidate the spectrum of regenerative responses. The high drug-metabolizing enzyme activity of RCLs, as demonstrated in our study, provides a promising avenue for investigating drug-induced liver injury mechanisms, contributing to a more detailed understanding of early drug discovery processes.
长期以来,创建体外人体肝脏模型一直是学术、临床和制药研究的重要目标,尤其是在药物开发方面,准确评估肝脏代谢动态至关重要。我们开发了一种生物工程灌注器官级人体肝脏模型,它能准确复制肝脏的主要功能,包括代谢活动和蛋白质合成,从而解决了传统肝脏单层、器官组织和基质包埋肝细胞的一些局限性。我们的方法利用肝脏特异性生物基质支架,采用创新方案制备,并添加了促进细胞相互作用的基质成分。这些支架在接种人类胎儿肝细胞或与肝实质细胞系和内皮细胞系共同接种后,可形成具有增强细胞组织的三维(3D)人类肝脏。对 "再细胞化组织工程肝脏"(RCL)进行了各种分析,证明了其在体内外建立肝脏微环境的能力。在 7-14 天内,RCLs 显示出肝脏分化和新陈代谢能力的证据,突出了用于药物代谢和毒性研究的潜力。尽管我们的研究向前迈进了一大步,但我们承认还需要与现有模型进行直接比较,并开展进一步研究,以充分阐明再生反应的范围。我们的研究表明,RCL 具有很高的药物代谢酶活性,这为研究药物诱导的肝损伤机制提供了一个很有前景的途径,有助于更详细地了解早期药物发现过程。
{"title":"Decellularized liver scaffolds for constructing drug-metabolically functional ex vivo human liver models","authors":"Juan Liu ,&nbsp;Ariel Hanson ,&nbsp;Wenzhen Yin ,&nbsp;Qiao Wu ,&nbsp;Eliane Wauthier ,&nbsp;Jinmei Diao ,&nbsp;Timothy Dinh ,&nbsp;Jeff Macdonald ,&nbsp;Ruihong Li ,&nbsp;Masahiko Terajima ,&nbsp;Mitsuo Yamauchi ,&nbsp;Ziye Chen ,&nbsp;Praveen Sethupathy ,&nbsp;Jiahong Dong ,&nbsp;Lola M. Reid ,&nbsp;Yunfang Wang","doi":"10.1016/j.bioactmat.2024.09.029","DOIUrl":"10.1016/j.bioactmat.2024.09.029","url":null,"abstract":"<div><div>The creation of <em>ex vivo</em> human liver models has long been a critical objective in academic, clinical, and pharmaceutical research, particularly for drug development, where accurate evaluation of hepatic metabolic dynamics is crucial. We have developed a bioengineered, perfused, organ-level human liver model that accurately replicates key liver functions, including metabolic activities, and protein synthesis, thus addressing some of the limitations associated with traditional liver monolayers, organoids, and matrix-embedded liver cells. Our approach utilizes liver-specific biomatrix scaffolds, prepared using an innovative protocol and fortified with matrix components that facilitate cellular interactions. These scaffolds, when seeded with human fetal liver cells or co-seeded with liver parenchymal and endothelial cell lines, enable the formation of three-dimensional (3D) human livers with enhanced cellular organization. The “recellularized tissue-engineered livers” (RCLs) have undergone various analyses, demonstrating the capability for establishing liver microenvironments <em>ex vivo</em>. Within 7–14 days, the RCLs exhibit evidence of liver differentiation and metabolic capabilities, underscoring the potential for use in drug metabolism and toxicity studies. Although our study represents a significant step forward, we acknowledge the need for direct comparisons with existing models and further research to fully elucidate the spectrum of regenerative responses. The high drug-metabolizing enzyme activity of RCLs, as demonstrated in our study, provides a promising avenue for investigating drug-induced liver injury mechanisms, contributing to a more detailed understanding of early drug discovery processes.</div></div>","PeriodicalId":8762,"journal":{"name":"Bioactive Materials","volume":"43 ","pages":"Pages 162-180"},"PeriodicalIF":18.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2452199X24004328/pdfft?md5=da2c266d1686d584cfb729b11247653c&pid=1-s2.0-S2452199X24004328-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the potential of laser-textured metal alloys: Fine-tuning vascular cells responses through in vitro and ex vivo analysis 探索激光纹理金属合金的潜力:通过体外和体内分析微调血管细胞反应
IF 18 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-09-23 DOI: 10.1016/j.bioactmat.2024.09.019
Indong Jun , Haneul Choi , Hyeok Kim , Byoung Chan Choi , Hye Jung Chang , Youngjun Kim , Sung Woo Cho , James R. Edwards , Suk-Won Hwang , Yu-Chan Kim , Hyung-Seop Han , Hojeong Jeon
Medical stents are vital for treating vascular complications and restoring blood flow in millions of patients. Despite its widespread effectiveness, restenosis, driven by the complex interplay of cellular responses, remains a concern. This study investigated the reactions of vascular cells to nano/microscale wrinkle (nano-W and micro-W) patterns created on laser-textured nitinol (NiTi) surfaces by adjusting laser processing parameters, such as spot overlap ratio and line overlap ratio. Evaluation of topographical effects on endothelial and smooth muscle cells (SMCs) revealed diverse morphologies, proliferation rates, and gene expressions. Notably, microscale wrinkle patterns exhibited reduced monocyte adhesion and inflammation-related gene expression, demonstrating their potential applications in mitigating vascular complications after stent insertion. Additionally, an ex vivo metatarsal assay was utilized to bridge the gap between in vitro and in vivo studies, demonstrating enhanced angiogenesis on laser-textured NiTi surfaces. Laser-textured NiTi exhibits a guided formation process, emphasizing their potential to promote swift endothelialization. These findings underscore the efficacy of laser texturing for tailored cellular interactions on metallic surfaces and offer valuable insights into optimizing biocompatibility and controlling cellular responses, which may pave the way for innovative advances in vascular care and contribute to the ongoing improvement of stent insertion.
医用支架对于治疗血管并发症和恢复数百万患者的血流至关重要。尽管其广泛有效,但由于细胞反应的复杂相互作用,再狭窄仍然是一个令人担忧的问题。这项研究通过调整激光加工参数,如光斑重叠率和线重叠率,研究了血管细胞对激光纹理镍钛醇(NiTi)表面产生的纳米/微米级皱纹(纳米-W 和微米-W)图案的反应。通过评估地形对内皮细胞和平滑肌细胞(SMC)的影响,发现了不同的形态、增殖率和基因表达。值得注意的是,微尺度皱纹图案减少了单核细胞的粘附和炎症相关基因的表达,显示了其在减轻支架插入后血管并发症方面的潜在应用。此外,为了缩小体外和体内研究之间的差距,还采用了体内外跖骨试验,结果表明激光纹理镍钛表面的血管生成得到了增强。激光纹理镍钛表现出一种引导形成过程,强调了其促进快速内皮化的潜力。这些发现强调了激光纹理在定制金属表面细胞相互作用方面的功效,并为优化生物相容性和控制细胞反应提供了宝贵的见解,这可能会为血管护理的创新进步铺平道路,并有助于不断改进支架插入技术。
{"title":"Exploring the potential of laser-textured metal alloys: Fine-tuning vascular cells responses through in vitro and ex vivo analysis","authors":"Indong Jun ,&nbsp;Haneul Choi ,&nbsp;Hyeok Kim ,&nbsp;Byoung Chan Choi ,&nbsp;Hye Jung Chang ,&nbsp;Youngjun Kim ,&nbsp;Sung Woo Cho ,&nbsp;James R. Edwards ,&nbsp;Suk-Won Hwang ,&nbsp;Yu-Chan Kim ,&nbsp;Hyung-Seop Han ,&nbsp;Hojeong Jeon","doi":"10.1016/j.bioactmat.2024.09.019","DOIUrl":"10.1016/j.bioactmat.2024.09.019","url":null,"abstract":"<div><div>Medical stents are vital for treating vascular complications and restoring blood flow in millions of patients. Despite its widespread effectiveness, restenosis, driven by the complex interplay of cellular responses, remains a concern. This study investigated the reactions of vascular cells to nano/microscale wrinkle (nano-W and micro-W) patterns created on laser-textured nitinol (NiTi) surfaces by adjusting laser processing parameters, such as spot overlap ratio and line overlap ratio. Evaluation of topographical effects on endothelial and smooth muscle cells (SMCs) revealed diverse morphologies, proliferation rates, and gene expressions. Notably, microscale wrinkle patterns exhibited reduced monocyte adhesion and inflammation-related gene expression, demonstrating their potential applications in mitigating vascular complications after stent insertion. Additionally, an <em>ex vivo</em> metatarsal assay was utilized to bridge the gap between <em>in vitro</em> and <em>in vivo</em> studies, demonstrating enhanced angiogenesis on laser-textured NiTi surfaces. Laser-textured NiTi exhibits a guided formation process, emphasizing their potential to promote swift endothelialization. These findings underscore the efficacy of laser texturing for tailored cellular interactions on metallic surfaces and offer valuable insights into optimizing biocompatibility and controlling cellular responses, which may pave the way for innovative advances in vascular care and contribute to the ongoing improvement of stent insertion.</div></div>","PeriodicalId":8762,"journal":{"name":"Bioactive Materials","volume":"43 ","pages":"Pages 181-194"},"PeriodicalIF":18.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2452199X24004146/pdfft?md5=6d85835fa7ef9c1431888e2fda8d3024&pid=1-s2.0-S2452199X24004146-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human bone tissue-derived ECM hydrogels: Controlling physicochemical, biochemical, and biological properties through processing parameters 源自人体骨组织的 ECM 水凝胶:通过加工参数控制物理化学、生物化学和生物学特性
IF 18 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-09-23 DOI: 10.1016/j.bioactmat.2024.09.007
Yang-Hee Kim , Gianluca Cidonio , Janos M. Kanczler , Richard OC. Oreffo , Jonathan I. Dawson
Decellularized tissues offer significant potential as biological materials for tissue regeneration given their ability to preserve the complex compositions and architecture of the native extracellular matrix (ECM). However, the evaluation and derivation of decellularized matrices from human bone tissue remains largely unexplored. We examined how the physiochemical and biological properties of ECM hydrogels derived from human bone ECM could be controlled by manipulating bone powder size (45–250 μm, 250–1000 μm, and 1000–2000 μm) and ECM composition through modulation of enzyme digestion time (3-5-7 days).
A reduction in material bone powder size and an increase in ECM digestion time produced enhanced protein concentrations in the ECM hydrogels, accompanied by the presence of a diverse array of proteins and improved gelation strength. Human bone marrow-derived stromal cells (HBMSCs) cultured on ECM hydrogels from 45 to 250 μm bone powder, over 7 days, demonstrated enhanced osteogenic differentiation compared to hydrogels derived from larger bone powders and collagen gels confirming the potential of the hydrogels as biologically active materials for bone regeneration. Digestion time and bone powder size modulation enabled the generation of hydrogels with enhanced release of ECM proteins and appropriate gelation and rheological properties, offering new opportunities for application in bone repair.
由于脱细胞组织能够保留原生细胞外基质(ECM)的复杂成分和结构,因此作为组织再生的生物材料具有巨大的潜力。然而,对人体骨组织脱细胞基质的评估和衍生在很大程度上仍有待探索。我们研究了如何通过调节骨粉大小(45-250 μm、250-1000 μm、1000-2000 μm)和酶消化时间(3-5-7 天)来控制源自人体骨 ECM 的 ECM 水凝胶的理化和生物学特性。与来自较大骨粉和胶原凝胶的水凝胶相比,在 45 到 250 μm 骨粉的 ECM 水凝胶上培养 7 天的人类骨髓基质细胞(HBMSCs)显示出更强的成骨分化能力,这证实了水凝胶作为骨再生生物活性材料的潜力。消化时间和骨粉大小的调节使生成的水凝胶具有更强的 ECM 蛋白释放能力以及适当的凝胶化和流变特性,为骨修复的应用提供了新的机遇。
{"title":"Human bone tissue-derived ECM hydrogels: Controlling physicochemical, biochemical, and biological properties through processing parameters","authors":"Yang-Hee Kim ,&nbsp;Gianluca Cidonio ,&nbsp;Janos M. Kanczler ,&nbsp;Richard OC. Oreffo ,&nbsp;Jonathan I. Dawson","doi":"10.1016/j.bioactmat.2024.09.007","DOIUrl":"10.1016/j.bioactmat.2024.09.007","url":null,"abstract":"<div><div>Decellularized tissues offer significant potential as biological materials for tissue regeneration given their ability to preserve the complex compositions and architecture of the native extracellular matrix (ECM). However, the evaluation and derivation of decellularized matrices from human bone tissue remains largely unexplored. We examined how the physiochemical and biological properties of ECM hydrogels derived from human bone ECM could be controlled by manipulating bone powder size (45–250 μm, 250–1000 μm, and 1000–2000 μm) and ECM composition through modulation of enzyme digestion time (3-5-7 days).</div><div>A reduction in material bone powder size and an increase in ECM digestion time produced enhanced protein concentrations in the ECM hydrogels, accompanied by the presence of a diverse array of proteins and improved gelation strength. Human bone marrow-derived stromal cells (HBMSCs) cultured on ECM hydrogels from 45 to 250 μm bone powder, over 7 days, demonstrated enhanced osteogenic differentiation compared to hydrogels derived from larger bone powders and collagen gels confirming the potential of the hydrogels as biologically active materials for bone regeneration. Digestion time and bone powder size modulation enabled the generation of hydrogels with enhanced release of ECM proteins and appropriate gelation and rheological properties, offering new opportunities for application in bone repair.</div></div>","PeriodicalId":8762,"journal":{"name":"Bioactive Materials","volume":"43 ","pages":"Pages 114-128"},"PeriodicalIF":18.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2452199X24003943/pdfft?md5=8180352a5ca6afb870b4b441ec3f14ab&pid=1-s2.0-S2452199X24003943-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanotechnology approaches to drug delivery for the treatment of ischemic stroke 治疗缺血性中风的纳米技术给药方法
IF 18 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-09-23 DOI: 10.1016/j.bioactmat.2024.09.016
Bin Peng , Farrah S. Mohammed , Xiangjun Tang , Jia Liu , Kevin N. Sheth , Jiangbing Zhou
Ischemic stroke is a major global public health concern that lacks effective treatment options. A significant challenge lies in delivering therapeutic agents to the brain due to the restrictive nature of the blood-brain barrier (BBB). The BBB's selectivity hampers the delivery of therapeutically relevant quantities of agents to the brain, resulting in a lack of FDA-approved pharmacotherapies for stroke. In this article, we review therapeutic agents that have been evaluated in clinical trials or are currently undergoing clinical trials. Subsequently, we survey strategies for synthesizing and engineering nanoparticles (NPs) for drug delivery to the ischemic brain. We then provide insights into the potential clinical translation of nanomedicine, offering a perspective on its transformative role in advancing stroke treatment strategies. In summary, existing literature suggests that drug delivery represents a major barrier for clinical translation of stroke pharmacotherapies. While nanotechnology has shown significant promise in addressing this challenge, further advancements aimed at improving delivery efficiency and simplifying formulations are necessary for successful clinical translation.
缺血性中风是全球关注的重大公共卫生问题,但缺乏有效的治疗方案。由于血脑屏障(BBB)的限制性,向大脑输送治疗药物面临巨大挑战。血脑屏障的选择性阻碍了治疗药物向大脑的输送,导致缺乏经 FDA 批准的中风药物疗法。本文回顾了已在临床试验中进行评估或正在进行临床试验的治疗药物。随后,我们介绍了用于向缺血性脑部递送药物的纳米颗粒(NPs)的合成和工程设计策略。然后,我们深入探讨了纳米医学的潜在临床转化,并对其在推进中风治疗策略方面的变革性作用提出了看法。总之,现有文献表明,药物输送是中风药物治疗临床转化的主要障碍。虽然纳米技术在应对这一挑战方面已显示出巨大前景,但要成功实现临床转化,还需要进一步提高给药效率和简化制剂。
{"title":"Nanotechnology approaches to drug delivery for the treatment of ischemic stroke","authors":"Bin Peng ,&nbsp;Farrah S. Mohammed ,&nbsp;Xiangjun Tang ,&nbsp;Jia Liu ,&nbsp;Kevin N. Sheth ,&nbsp;Jiangbing Zhou","doi":"10.1016/j.bioactmat.2024.09.016","DOIUrl":"10.1016/j.bioactmat.2024.09.016","url":null,"abstract":"<div><div>Ischemic stroke is a major global public health concern that lacks effective treatment options. A significant challenge lies in delivering therapeutic agents to the brain due to the restrictive nature of the blood-brain barrier (BBB). The BBB's selectivity hampers the delivery of therapeutically relevant quantities of agents to the brain, resulting in a lack of FDA-approved pharmacotherapies for stroke. In this article, we review therapeutic agents that have been evaluated in clinical trials or are currently undergoing clinical trials. Subsequently, we survey strategies for synthesizing and engineering nanoparticles (NPs) for drug delivery to the ischemic brain. We then provide insights into the potential clinical translation of nanomedicine, offering a perspective on its transformative role in advancing stroke treatment strategies. In summary, existing literature suggests that drug delivery represents a major barrier for clinical translation of stroke pharmacotherapies. While nanotechnology has shown significant promise in addressing this challenge, further advancements aimed at improving delivery efficiency and simplifying formulations are necessary for successful clinical translation.</div></div>","PeriodicalId":8762,"journal":{"name":"Bioactive Materials","volume":"43 ","pages":"Pages 145-161"},"PeriodicalIF":18.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2452199X24004110/pdfft?md5=2ef3b032d88425c0605caa3649281691&pid=1-s2.0-S2452199X24004110-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A polymer nanogel-based therapeutic nanovaccine for prophylaxis and direct treatment of tumors via a full-cycle immunomodulation 基于聚合物纳米凝胶的治疗性纳米疫苗,可通过全周期免疫调节预防和直接治疗肿瘤
IF 18 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-09-23 DOI: 10.1016/j.bioactmat.2024.09.024
Yunqi Guo , Zhiqiang Wang , Gaoming Li , Mengsi Zhan , Tingting Xiao , Jianhong Wang , Jan C.M. van Hest , Xiangyang Shi , Mingwu Shen
Construction of a cancer nanovaccine that can simultaneously activate immune cells and exert efficient tumor treatment still remains a challenge. Herein, we showcase a proof-of-concept demonstration of an advanced therapeutic nanovaccine formulation based on poly(N-vinylcaprolactam) nanogels (NGs) which were loaded with manganese dioxide (MnO2), the sonosensitizer chlorin e6 (Ce6), and the immune adjuvant cyclic GMP-AMP (cGAMP). The gels were furthermore coated with apoptotic cancer cell membranes (AM). On the one hand, the AM promoted the recognition of NGs by antigen presenting cells (APCs) in lymph nodes due to their enhanced immunogenicity, then the loaded Mn and cGAMP could mature APCs via stimulator of interferon genes (STING) activation for triggering immunity to prevent tumor growth. On the other hand, the NGs could selectively release Mn2+ for hydroxyl radical production and Ce6 to generate single oxygen under ultrasound irradiation of tumors, respectively, thereby exerting local chemodynamic/sonodynamic therapy to induce immunogenic cell death (ICD). Moreover, the Mn2+ could also activate STING in tumors to synergize with ICD for potentiated immune responses. Overall, the biomimetic NG-based therapeutic nanovaccine could directly evoke immune system, and also conduct local tumor treatment to further activate ICD, thus realizing a full-cycle immunomodulation (tumor killing for ICD/antigen production, and tumor cells/APCs immune activation) to tackle bilateral tumor growth.
构建一种既能激活免疫细胞又能有效治疗肿瘤的癌症纳米疫苗仍是一项挑战。在此,我们展示了一种基于聚(N-乙烯基己内酰胺)纳米凝胶(NGs)的先进治疗性纳米疫苗配方的概念验证。凝胶上还涂有凋亡癌细胞膜(AM)。一方面,由于免疫原性增强,AM 可促进淋巴结中的抗原呈递细胞(APCs)识别 NG,然后负载的 Mn 和 cGAMP 可通过激活干扰素基因刺激因子(STING)使 APCs 成熟,从而触发免疫以阻止肿瘤生长。另一方面,在超声波照射肿瘤时,NGs 可选择性地释放 Mn2+ 产生羟基自由基,释放 Ce6 产生单氧,从而发挥局部化学动力学/声动力学疗法的作用,诱导免疫原性细胞死亡(ICD)。此外,Mn2+还能激活肿瘤中的STING,与ICD协同作用,增强免疫反应。总之,基于仿生 NG 的治疗性纳米疫苗既能直接唤起免疫系统,又能对肿瘤进行局部治疗,进一步激活 ICD,从而实现全周期免疫调节(ICD/抗原产生的肿瘤杀伤,以及肿瘤细胞/APCs 的免疫激活),以应对肿瘤的双侧生长。
{"title":"A polymer nanogel-based therapeutic nanovaccine for prophylaxis and direct treatment of tumors via a full-cycle immunomodulation","authors":"Yunqi Guo ,&nbsp;Zhiqiang Wang ,&nbsp;Gaoming Li ,&nbsp;Mengsi Zhan ,&nbsp;Tingting Xiao ,&nbsp;Jianhong Wang ,&nbsp;Jan C.M. van Hest ,&nbsp;Xiangyang Shi ,&nbsp;Mingwu Shen","doi":"10.1016/j.bioactmat.2024.09.024","DOIUrl":"10.1016/j.bioactmat.2024.09.024","url":null,"abstract":"<div><div>Construction of a cancer nanovaccine that can simultaneously activate immune cells and exert efficient tumor treatment still remains a challenge. Herein, we showcase a proof-of-concept demonstration of an advanced therapeutic nanovaccine formulation based on poly(<em>N</em>-vinylcaprolactam) nanogels (NGs) which were loaded with manganese dioxide (MnO<sub>2</sub>), the sonosensitizer chlorin e6 (Ce6), and the immune adjuvant cyclic GMP-AMP (cGAMP). The gels were furthermore coated with apoptotic cancer cell membranes (AM). On the one hand, the AM promoted the recognition of NGs by antigen presenting cells (APCs) in lymph nodes due to their enhanced immunogenicity, then the loaded Mn and cGAMP could mature APCs <em>via</em> stimulator of interferon genes (STING) activation for triggering immunity to prevent tumor growth. On the other hand, the NGs could selectively release Mn<sup>2+</sup> for hydroxyl radical production and Ce6 to generate single oxygen under ultrasound irradiation of tumors, respectively, thereby exerting local chemodynamic/sonodynamic therapy to induce immunogenic cell death (ICD). Moreover, the Mn<sup>2+</sup> could also activate STING in tumors to synergize with ICD for potentiated immune responses. Overall, the biomimetic NG-based therapeutic nanovaccine could directly evoke immune system, and also conduct local tumor treatment to further activate ICD, thus realizing a full-cycle immunomodulation (tumor killing for ICD/antigen production, and tumor cells/APCs immune activation) to tackle bilateral tumor growth.</div></div>","PeriodicalId":8762,"journal":{"name":"Bioactive Materials","volume":"43 ","pages":"Pages 129-144"},"PeriodicalIF":18.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2452199X24004195/pdfft?md5=c9c514d45c976f5746f0b582b357bcf9&pid=1-s2.0-S2452199X24004195-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthetic helical peptides on nanofibers to activate cell-surface receptors and synergistically enhance critical-sized bone defect regeneration 纳米纤维上的合成螺旋肽可激活细胞表面受体并协同促进临界骨缺损再生
IF 18 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-09-21 DOI: 10.1016/j.bioactmat.2024.08.017
Tongqing Zhou , Rafael C. Cavalcante , Chunxi Ge , Renny T. Franceschi , Peter X. Ma
More than 500,000 bone grafting procedures are performed annually in the USA. Considering the significant limitations of available bone grafts, we previously invented a phase-separation technology to generate nanofibrous poly(l-lactic acid) (PLLA) scaffolds that mimic the bone matrix collagen in nanofiber geometry and enhance bone regeneration. Here we report the development of nanofibrous scaffolds with covalently attached synthetic peptides that mimic native collagen peptides to activate the two main collagen receptors in bone cells, discoidin domain receptor 2 (DDR2) and β1 integrins. We synthesized a PLLA-based graft-copolymer to enable covalent peptide conjugation via a click reaction. Using PLLA and the graft-copolymer, we developed 3D scaffolds with interconnected pores and peptides-containing nanofibers to activate DDR2 and β1 integrins of osteogenic cells. The degradation rate and mechanical properties of the scaffolds are tunable. The peptides-decorated nanofibrous scaffolds demonstrated 7.8 times more mineralized bone regeneration over the control scaffolds without the peptides in a critical-sized bone defect regeneration model after 8 weeks of implantation, showing a synergistic effect of the two peptides. This study demonstrates the power of scaffolds to mimic ECM at both nanometer and molecular levels, activating cell surface receptors to liberate the innate regenerative potential of host stem/progenitor cells.
美国每年进行的骨移植手术超过 50 万例。考虑到现有骨移植材料的巨大局限性,我们之前发明了一种相分离技术,用于生成纳米纤维状聚(l-乳酸)(PLLA)支架,这种支架以纳米纤维的几何形状模拟骨基质胶原蛋白,并促进骨再生。在这里,我们报告了纳米纤维支架的开发情况,支架上共价连接的合成肽能模拟原生胶原蛋白肽,从而激活骨细胞中的两种主要胶原蛋白受体--盘状蛋白结构域受体 2(DDR2)和β1整合素。我们合成了一种基于聚乳酸(PLLA)的接枝共聚物,通过点击反应实现共价肽连接。利用聚乳酸和接枝共聚物,我们开发出了具有相互连接的孔隙和含肽纳米纤维的三维支架,以激活成骨细胞的 DDR2 和 β1 整合素。这种支架的降解率和机械性能是可调的。在临界大小骨缺损再生模型中,多肽装饰的纳米纤维支架在植入 8 周后的矿化骨再生能力是不含多肽的对照支架的 7.8 倍,显示了两种多肽的协同作用。这项研究表明,支架能在纳米和分子水平上模拟 ECM,激活细胞表面受体,释放宿主干细胞/祖细胞的先天再生潜能。
{"title":"Synthetic helical peptides on nanofibers to activate cell-surface receptors and synergistically enhance critical-sized bone defect regeneration","authors":"Tongqing Zhou ,&nbsp;Rafael C. Cavalcante ,&nbsp;Chunxi Ge ,&nbsp;Renny T. Franceschi ,&nbsp;Peter X. Ma","doi":"10.1016/j.bioactmat.2024.08.017","DOIUrl":"10.1016/j.bioactmat.2024.08.017","url":null,"abstract":"<div><div>More than 500,000 bone grafting procedures are performed annually in the USA. Considering the significant limitations of available bone grafts, we previously invented a phase-separation technology to generate nanofibrous poly(<span>l</span>-lactic acid) (PLLA) scaffolds that mimic the bone matrix collagen in nanofiber geometry and enhance bone regeneration. Here we report the development of nanofibrous scaffolds with covalently attached synthetic peptides that mimic native collagen peptides to activate the two main collagen receptors in bone cells, discoidin domain receptor 2 (DDR2) and β1 integrins. We synthesized a PLLA-based graft-copolymer to enable covalent peptide conjugation via a click reaction. Using PLLA and the graft-copolymer, we developed 3D scaffolds with interconnected pores and peptides-containing nanofibers to activate DDR2 and β1 integrins of osteogenic cells. The degradation rate and mechanical properties of the scaffolds are tunable. The peptides-decorated nanofibrous scaffolds demonstrated 7.8 times more mineralized bone regeneration over the control scaffolds without the peptides in a critical-sized bone defect regeneration model after 8 weeks of implantation, showing a synergistic effect of the two peptides. This study demonstrates the power of scaffolds to mimic ECM at both nanometer and molecular levels, activating cell surface receptors to liberate the innate regenerative potential of host stem/progenitor cells.</div></div>","PeriodicalId":8762,"journal":{"name":"Bioactive Materials","volume":"43 ","pages":"Pages 98-113"},"PeriodicalIF":18.0,"publicationDate":"2024-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2452199X24003554/pdfft?md5=4187768ed883c4d9f3418a249d784f09&pid=1-s2.0-S2452199X24003554-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound-generated bubbles enhance osteogenic differentiation of mesenchymal stromal cells in composite collagen hydrogels 超声产生的气泡能增强复合胶原水凝胶中间充质基质细胞的成骨分化能力
IF 18 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-09-20 DOI: 10.1016/j.bioactmat.2024.09.018
Somnath Maji , Mitra Aliabouzar , Carole Quesada , Anjali Chiravuri , Aidan Macpherson , Abigail Pinch , Karsyn Kazyak , Ziyad Emara , Bachir A. Abeid , Robert N. Kent III , Firaol S. Midekssa , Man Zhang , Brendon M. Baker , Renny T. Franceschi , Mario L. Fabiilli
Hydrogels can improve the delivery of mesenchymal stromal cells (MSCs) by providing crucial biophysical cues that mimic the extracellular matrix. The differentiation of MSCs is dependent on biophysical cues like stiffness and viscoelasticity, yet conventional hydrogels cannot be dynamically altered after fabrication and implantation to actively direct differentiation. We developed a composite hydrogel, consisting of type I collagen and phase-shift emulsion, where osteogenic differentiation of MSCs can be non-invasively modulated using ultrasound. When exposed to ultrasound, the emulsion within the hydrogel was non-thermally vaporized into bubbles, which locally compacted and stiffened the collagen matrix surrounding each bubble. Bubble growth and matrix compaction were correlated, with collagen regions proximal (i.e., ≤ ∼60 μm) to the bubble displaying a 2.5-fold increase in Young's modulus compared to distal regions (i.e., > ∼60 μm). The viability and proliferation of MSCs, which were encapsulated within the composite hydrogel, were not impacted by bubble formation. In vitro and in vivo studies revealed encapsulated MSCs exhibited significantly elevated levels of RUNX2 and osteocalcin, markers of osteogenic differentiation, in collagen regions proximal to the bubble compared to distal regions. Additionally, alkaline phosphatase activity and calcium deposition were enhanced adjacent to the bubble. An opposite trend was observed for CD90, a marker of MSC stemness. Following subcutaneous implantation, bubbles persisted in the hydrogels for two weeks, which led to localized collagen alignment and increases in nuclear asymmetry. These results are a significant step toward controlling the 3D differentiation of MSCs in a non-invasive and on-demand manner.
水凝胶可提供模拟细胞外基质的关键生物物理线索,从而改善间充质基质细胞(MSCs)的输送。间充质干细胞的分化依赖于刚度和粘弹性等生物物理线索,但传统的水凝胶在制造和植入后无法动态改变,无法积极引导分化。我们开发了一种由 I 型胶原蛋白和相移乳液组成的复合水凝胶,可利用超声波无创调节间充质干细胞的成骨分化。当暴露于超声波时,水凝胶中的乳液会非热气化成气泡,从而局部压实和硬化每个气泡周围的胶原基质。气泡的生长与基质的压实相关,气泡近端(即≤ ∼60 μm)的胶原区域的杨氏模量比远端(即 > ∼60 μm)增加了 2.5 倍。包裹在复合水凝胶中的间充质干细胞的活力和增殖不受气泡形成的影响。体外和体内研究显示,与远端区域相比,气泡近端胶原区域包裹的间充质干细胞显示出明显升高的成骨分化标志物 RUNX2 和骨钙素水平。此外,气泡附近的碱性磷酸酶活性和钙沉积也有所增强。间充质干细胞干性标志物CD90则呈现相反趋势。皮下植入后,气泡在水凝胶中持续存在两周,导致局部胶原排列和核不对称增加。这些结果为以非侵入性和按需方式控制间叶干细胞的三维分化迈出了重要一步。
{"title":"Ultrasound-generated bubbles enhance osteogenic differentiation of mesenchymal stromal cells in composite collagen hydrogels","authors":"Somnath Maji ,&nbsp;Mitra Aliabouzar ,&nbsp;Carole Quesada ,&nbsp;Anjali Chiravuri ,&nbsp;Aidan Macpherson ,&nbsp;Abigail Pinch ,&nbsp;Karsyn Kazyak ,&nbsp;Ziyad Emara ,&nbsp;Bachir A. Abeid ,&nbsp;Robert N. Kent III ,&nbsp;Firaol S. Midekssa ,&nbsp;Man Zhang ,&nbsp;Brendon M. Baker ,&nbsp;Renny T. Franceschi ,&nbsp;Mario L. Fabiilli","doi":"10.1016/j.bioactmat.2024.09.018","DOIUrl":"10.1016/j.bioactmat.2024.09.018","url":null,"abstract":"<div><div>Hydrogels can improve the delivery of mesenchymal stromal cells (MSCs) by providing crucial biophysical cues that mimic the extracellular matrix. The differentiation of MSCs is dependent on biophysical cues like stiffness and viscoelasticity, yet conventional hydrogels cannot be dynamically altered after fabrication and implantation to actively direct differentiation. We developed a composite hydrogel, consisting of type I collagen and phase-shift emulsion, where osteogenic differentiation of MSCs can be non-invasively modulated using ultrasound. When exposed to ultrasound, the emulsion within the hydrogel was non-thermally vaporized into bubbles, which locally compacted and stiffened the collagen matrix surrounding each bubble. Bubble growth and matrix compaction were correlated, with collagen regions proximal (i.e., ≤ ∼60 μm) to the bubble displaying a 2.5-fold increase in Young's modulus compared to distal regions (i.e., &gt; ∼60 μm). The viability and proliferation of MSCs, which were encapsulated within the composite hydrogel, were not impacted by bubble formation. In vitro and in vivo studies revealed encapsulated MSCs exhibited significantly elevated levels of RUNX2 and osteocalcin, markers of osteogenic differentiation, in collagen regions proximal to the bubble compared to distal regions. Additionally, alkaline phosphatase activity and calcium deposition were enhanced adjacent to the bubble. An opposite trend was observed for CD90, a marker of MSC stemness. Following subcutaneous implantation, bubbles persisted in the hydrogels for two weeks, which led to localized collagen alignment and increases in nuclear asymmetry. These results are a significant step toward controlling the 3D differentiation of MSCs in a non-invasive and on-demand manner.</div></div>","PeriodicalId":8762,"journal":{"name":"Bioactive Materials","volume":"43 ","pages":"Pages 82-97"},"PeriodicalIF":18.0,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2452199X24004134/pdfft?md5=842cd8864555fbae5d544a543d05e17a&pid=1-s2.0-S2452199X24004134-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Silver-quercetin-loaded honeycomb-like Ti-based interface combats infection-triggered excessive inflammation via specific bactericidal and macrophage reprogramming 负载银槲皮素的蜂窝状钛基界面通过特异性杀菌和巨噬细胞重编程作用对抗感染引发的过度炎症
IF 18 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-09-17 DOI: 10.1016/j.bioactmat.2024.09.012
Ning Yang , Ting Wu , Meng Li , Xianli Hu , Ruixiang Ma , Wei Jiang , Zheng Su , Rong Yang , Chen Zhu

Excessive inflammation caused by bacterial infection is the primary cause of implant failure. Antibiotic treatment often fails to prevent peri-implant infection and may induce unexpected drug resistance. Herein, a non-antibiotic strategy based on the synergy of silver ion release and macrophage reprogramming is proposed for preventing infection and bacteria-induced inflammation suppression by the organic-inorganic hybridization of silver nanoparticle (AgNP) and quercetin (Que) into a polydopamine (PDA)-based coating on the 3D framework of porous titanium (SQPdFT). Once the planktonic bacteria (e.g., Escherichia coli, Staphylococcus aureus) reach the surface of SQPdFT, released Que disrupts the bacterial membrane. Then, AgNP can penetrate the invading bacterium and kill them, which further inhibits the biofilm formation. Simultaneously, released Que can regulate macrophage polarization homeostasis via the peroxisome proliferators-activated receptors gamma (PPARγ)-mediated nuclear factor kappa-B (NF-κB) pathway, thereby terminating excessive inflammatory responses. These advantages facilitate the adhesion and osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs), concomitantly suppressing osteoclast maturation, and eventually conferring superior mechanical stability to SQPdFT within the medullary cavity. In summary, owing to its excellent antibacterial effect, immune remodeling function, and pro-osteointegration ability, SQPdFT is a promising protective coating for titanium-based implants used in orthopedic replacement surgery.

细菌感染引起的过度炎症是导致种植失败的主要原因。抗生素治疗往往无法预防种植体周围感染,还可能诱发意想不到的耐药性。本文提出了一种基于银离子释放和巨噬细胞重编程协同作用的非抗生素策略,通过将银纳米粒子(AgNP)和槲皮素(Que)有机-无机杂化到多孔钛三维框架(SQPdFT)上的聚多巴胺(PDA)涂层中,来预防感染和抑制细菌引起的炎症。一旦浮游细菌(如大肠杆菌、金黄色葡萄球菌)到达 SQPdFT 表面,释放出的 Que 就会破坏细菌膜。然后,AgNP 可以穿透入侵的细菌并杀死它们,从而进一步抑制生物膜的形成。同时,释放的阙能通过过氧化物酶体增殖激活受体γ(PPARγ)介导的核因子卡巴-B(NF-κB)途径调节巨噬细胞的极化平衡,从而终止过度的炎症反应。这些优势有助于骨髓间充质干细胞(BMSCs)的粘附和成骨分化,同时抑制破骨细胞的成熟,最终使 SQPdFT 在髓腔内具有卓越的机械稳定性。总之,由于 SQPdFT 具有出色的抗菌效果、免疫重塑功能和促进骨整合能力,它是骨科置换手术中使用的钛基植入物的一种前景广阔的保护涂层。
{"title":"Silver-quercetin-loaded honeycomb-like Ti-based interface combats infection-triggered excessive inflammation via specific bactericidal and macrophage reprogramming","authors":"Ning Yang ,&nbsp;Ting Wu ,&nbsp;Meng Li ,&nbsp;Xianli Hu ,&nbsp;Ruixiang Ma ,&nbsp;Wei Jiang ,&nbsp;Zheng Su ,&nbsp;Rong Yang ,&nbsp;Chen Zhu","doi":"10.1016/j.bioactmat.2024.09.012","DOIUrl":"10.1016/j.bioactmat.2024.09.012","url":null,"abstract":"<div><p>Excessive inflammation caused by bacterial infection is the primary cause of implant failure. Antibiotic treatment often fails to prevent peri-implant infection and may induce unexpected drug resistance. Herein, a non-antibiotic strategy based on the synergy of silver ion release and macrophage reprogramming is proposed for preventing infection and bacteria-induced inflammation suppression by the organic-inorganic hybridization of silver nanoparticle (AgNP) and quercetin (Que) into a polydopamine (PDA)-based coating on the 3D framework of porous titanium (SQPdFT). Once the planktonic bacteria (<em>e.g., Escherichia coli</em>, <em>Staphylococcus aureus</em>) reach the surface of SQPdFT, released Que disrupts the bacterial membrane. Then, AgNP can penetrate the invading bacterium and kill them, which further inhibits the biofilm formation. Simultaneously, released Que can regulate macrophage polarization homeostasis via the peroxisome proliferators-activated receptors gamma (PPARγ)-mediated nuclear factor kappa-B (NF-κB) pathway, thereby terminating excessive inflammatory responses. These advantages facilitate the adhesion and osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs), concomitantly suppressing osteoclast maturation, and eventually conferring superior mechanical stability to SQPdFT within the medullary cavity. In summary, owing to its excellent antibacterial effect, immune remodeling function, and pro-osteointegration ability, SQPdFT is a promising protective coating for titanium-based implants used in orthopedic replacement surgery.</p></div>","PeriodicalId":8762,"journal":{"name":"Bioactive Materials","volume":"43 ","pages":"Pages 48-66"},"PeriodicalIF":18.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2452199X24003992/pdfft?md5=3c3dcaa59da76f55cd27e43ae114f8e3&pid=1-s2.0-S2452199X24003992-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142242367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune-modulative nano-gel-nano system for patient-favorable cancer therapy 用于治疗癌症的免疫调节纳米凝胶-纳米系统
IF 18 1区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-09-17 DOI: 10.1016/j.bioactmat.2024.08.047
Sung Hoon Kim , Rafael T. Han , Hyung-Seop Han , Young-Min Kim

Current cancer immunotherapies exhibit low response rates attributed to suppressive tumor immune microenvironments (TIMEs). To address these unfavorable TIMEs, supplementation with tumor-associated antigens and stimulation of immune cells at target sites are indispensable for eliciting anti-tumoral immune responses. Previous research has explored the induction of immunotherapy through multiple injections and implants; however, these approaches lack consideration for patient convenience and the implementation of finely tunable immune response control systems to mitigate the side effects of over-inflammatory responses, such as cytokine storms. In this context, we describe a patient-centric nano-gel-nano system capable of sustained generation of tumor-associated antigens and release of adjuvants. This is achieved through the specific delivery of drugs to cancer cells and antigens/adjuvants to immune cells over the long term, maintaining proper concentrations within the tumor site with a single injection. This system demonstrates local immunity against tumors with a single injection, enhances the therapeutic efficacy of immune checkpoint blockades, and induces systemic and memory T cell responses, thus minimizing systemic side effects.

由于肿瘤免疫微环境(TIME)的抑制,目前的癌症免疫疗法反应率很低。要解决这些不利的 TIMEs 问题,补充肿瘤相关抗原和刺激靶点的免疫细胞对于激发抗肿瘤免疫反应是必不可少的。以往的研究探索了通过多次注射和植入诱导免疫疗法的方法;然而,这些方法缺乏对患者便利性的考虑,也没有实施可微调的免疫反应控制系统,以减轻细胞因子风暴等过度炎症反应的副作用。在此背景下,我们描述了一种以患者为中心的纳米凝胶-纳米系统,该系统能够持续产生肿瘤相关抗原并释放佐剂。这是通过向癌细胞特异性地输送药物和向免疫细胞长期输送抗原/佐剂来实现的,只需一次注射就能在肿瘤部位保持适当的浓度。这种系统只需一次注射就能显示出对肿瘤的局部免疫力,提高免疫检查点阻断剂的疗效,并诱导全身性和记忆性 T 细胞反应,从而将全身性副作用降至最低。
{"title":"Immune-modulative nano-gel-nano system for patient-favorable cancer therapy","authors":"Sung Hoon Kim ,&nbsp;Rafael T. Han ,&nbsp;Hyung-Seop Han ,&nbsp;Young-Min Kim","doi":"10.1016/j.bioactmat.2024.08.047","DOIUrl":"10.1016/j.bioactmat.2024.08.047","url":null,"abstract":"<div><p>Current cancer immunotherapies exhibit low response rates attributed to suppressive tumor immune microenvironments (TIMEs). To address these unfavorable TIMEs, supplementation with tumor-associated antigens and stimulation of immune cells at target sites are indispensable for eliciting anti-tumoral immune responses. Previous research has explored the induction of immunotherapy through multiple injections and implants; however, these approaches lack consideration for patient convenience and the implementation of finely tunable immune response control systems to mitigate the side effects of over-inflammatory responses, such as cytokine storms. In this context, we describe a patient-centric nano-gel-nano system capable of sustained generation of tumor-associated antigens and release of adjuvants. This is achieved through the specific delivery of drugs to cancer cells and antigens/adjuvants to immune cells over the long term, maintaining proper concentrations within the tumor site with a single injection. This system demonstrates local immunity against tumors with a single injection, enhances the therapeutic efficacy of immune checkpoint blockades, and induces systemic and memory T cell responses, thus minimizing systemic side effects.</p></div>","PeriodicalId":8762,"journal":{"name":"Bioactive Materials","volume":"43 ","pages":"Pages 67-81"},"PeriodicalIF":18.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2452199X24003852/pdfft?md5=02c76c403a2d17a7f3bbf3b5cb54fc83&pid=1-s2.0-S2452199X24003852-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142242368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Bioactive Materials
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1